CPhI Prepares for India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Prepares for India


CPhI ands its collocated events take place in various other locations outside of Europe. Following the event’s departure from Madrid, it will only be a few weeks before pharmaceutical professionals are once again networking under the CPhI name; this time in Mumbai for CPhI India.

CPhI India will take place on 21–23 November at the Bombay Exhibition Centre and will also celebrate its sixth anniversary. According to the organisers, the Indian pharmaceutical market is growing at an annual rate of 13%, twice that of the global market growth rate.

Last year’s event featured 825 exhibitors from 21 countries and regions and more than 27000 attendees from 96 countries and regions. Visitor levels are not far behind CPhI Worldwide, which has been running for considerably longer than its Indian sister event.

CPhI India will also feature some of the same collocated events that are seen at the European show: P-MEC for pharmaceutical machinery, equipment and technology; ICSE for pharmaceutical contract services and outsourcing solutions; and BioPh for bio-solutions for pharma.

You can find out more about CPhI India here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here